Coave Therapeutics

Rodolphe Clerval, CEO

Paris, France

(Private)

Coave Therapeutics is a genetic medicine company pioneering the development of innovative solutions to enhance the precision, safety, efficacy and manufacturability of genetic medicines. With its proprietary ALIGATER™ platform, Coave is at the forefront of addressing challenges in gene therapy delivery to extra-hepatic tissues, creating a robust pipeline targeting CNS, neuromuscular and eye diseases.

www.coavetx.com



By using this website you agree to accept our Privacy Policy and Terms & Conditions